Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T80618 | Narlumosbart | 2646587-68-8 | 98% |
Narlumosbart
|
Narlumosbart (JMT103) is an IgG4κ monoclonal antibody that selectively binds to the receptor activator of nuclear factor-κB ligand (RANKL)[1]. | ||||
T61531 | NFATc1-IN-1 | 1912422-56-0 | 99.64% |
|
NFATc1-IN-1 (also known as compound A04) is a highly effective inhibitor of osteoclast formation induced by RANKL, with an IC50 of 1.57 μM. It exerts its anti-os... | ||||
T5720 | Boldine | 476-70-0 | 98% |
|
Boldine (1,10-Dimethoxy-2,9-dihydroxyaporphine) is a natual product .Boldine displays anti-cancer, cytoprotective , anti-oxidant and anti-inflammatory activities... | ||||
T5770 | Alisol B | 18649-93-9 | 98% |
|
Alisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions. Alisol... | ||||
T9917 | Denosumab | 615258-40-7 | 98% |
Denosumab
|
Denosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand |